Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of brimonidine and latanoprost in treatment of normal tension glaucoma
IRCT20120817010617N7Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of brimonidine and latanoprost in normal tension glaucoma (NTG), sponsored by Zahedan University of Medical Sciences. Started Mar 2021; status: completed.
02
Drugs
brimonidinelatanoprost
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on IRCT20120817010617N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120817010617N7.